IVD Centralized Procurement Fully Implemented, Laboratory Testing Fee Reform Poised for Launch.
As the windfall from industry growth fades, a period of deep adjustment has arrived. At this crossroads of transformation, channel survival and development face unprecedented challenges. Where lies the breakthrough? Where can new growth be found?
Conducted Nationwide Survey, a group of pioneers who confront real-world challenges and explore new pathways will gather at the "2nd Annual Summit on In Vitro Diagnostics Channel Development" for in-depth sharing.
Confronting the Dilemma:In a homogenized red ocean, how can precise product selection secure a first-mover advantage? Amidst stringent compliance requirements, how can steady volume growth be achieved? In a zero-sum game for existing market share, how can innovative models break through the deadlock? With manufacturer-distributor relationships being reshaped, how can symbiotic win-win outcomes be realized?
Exploring New Paths:Beyond Pure Distribution: How to Elevate the Core Value of Channels? Aligning with Policy Trends: How to Adapt and Navigate Economic Cycles? Breaking Out of the Status Quo: Where Lie the Opportunities in General Health, Home Testing, Integrated Diagnosis and Treatment, and Alzheimer’s Disease (AD)? Strategizing for Future Scenarios: How to Secure a First-Mover Advantage?
Joint Exploration: Pathways to Breakthroughs in the IVD Industry.



